Ankleshwar, India – July 22, 2024 – RUSAN PHARMA PRIVATE LIMITED, a pharmaceutical company based in India specializing in the area of addiction treatment and pain management, recently announced that ...

AbbVie’s $100 billion splurge on domestic manufacturing and R&D is continuing to come into focus, this time with a $380 million investment in two new active pharmaceutical ingredient manufactur | The ...

AbbVie invests $380 million to build two new API manufacturing facilities in North Chicago while Bora Pharmaceuticals Co., Ltd. and GSK have renewed a five-year global manufacturing partnership.

JGC Holdings, an engineering company headquartered in Yokohama, Japan, has been awarded a contract by Chugai Pharmaceutical to build an active pharmaceutical ingredient (API) manufacturing plant for ...

In this interview, NewsMed talks to Dr. James Mencel's Guidance about Scaling Up API Processes. Could you introduce yourself and your experience in the pharmaceutical industry? I obtained a B.S. in ...

The U.S. Food and Drug Administration has issued an establishment inspection report with a voluntary action indicated (VAI) classification to Natco Pharma’s active pharmaceutical ingredient (API) ...

The project, approved in 2008, was meant to anchor the industry’s next phase of growth. Nearly two decades later, the site remains largely idle. On a quiet December 11 afternoon, entering the API ...

"We are very excited to transition this fully-integrated API Pharmaceutical site, with its substantial reaction capacity, site infrastructure and attractive location, we are confident in the potential ...

Emzor Pharmaceutical Industries Limited has stated that its $23m Active Pharmaceutical Ingredient production plant would help to reduce Nigeria’s drug import by 2026. In a statement issued by the Head ...

Shares of the company are on investors' radar after its Hyderabad plant received GMP and Quality Management certifications ...